CoChat

RAB27A promotes melanoma cell invasion and metastasis via regulation of pro‐invasive exosomes

Guo, Dajiang, Lui, Goldie Y.L., Lai, Siew Li, Wilmott, James S., Tikoo, Shweta, Jackett, Louise A., Quek, Camelia, Brown, Darren L., Sharp, Danae M., Kwan, Rain Y.Q., Chacon, Diego, Wong, Jason H., Beck, Dominik, van Geldermalsen, Michelle, Holst, Jeff, Thompson, John F., Mann, Graham J., Scolyer, Richard A., Stow, Jennifer L., Weninger, Wolfgang, Haass, Nikolas K., Beaumont, Kimberley A. · 2019 · International Journal of Cancer
Cited by 103

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Despite recent advances in targeted and immune‐based therapies, advanced stage melanoma remains a clinical challenge with a poor prognosis. Understanding the genes and cellular processes that drive progression and metastasis is critical for identifying new therapeutic strategies. Here, we found that the GTPase RAB27A was overexpressed in a subset of melanomas, which correlated with poor patient survival. Loss of RAB27A expression in melanoma cell lines inhibited 3D spheroid invasion and cell motility in vitro, and spontaneous metastasis in vivo. The reduced invasion phenotype was rescued by RAB27A‐replete exosomes, but not RAB27A‐knockdown exosomes, indicating that RAB27A is responsible for the generation of pro‐invasive exosomes. Furthermore, while RAB27A loss did not alter the number of exosomes secreted, it did change exosome size and altered the composition and abundance of exosomal proteins, some of which are known to regulate cancer cell movement. Our data suggest that RAB27A promotes the biogenesis of a distinct pro‐invasive exosome population. These findings support RAB27A as a key cancer regulator, as well as a potential prognostic marker and therapeutic target in melanoma.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ijc.32064

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 103

Metadata

Authors
Guo, D., Lui, G. Y. L., Lai, S. L., Wilmott, J. S., Tikoo, S., Jackett, L. A., Quek, C., Brown, D. L., Sharp, D. M., Kwan, R. Y. Q., Chacon, D., Wong, J. H., Beck, D., van Geldermalsen, M., Holst, J., Thompson, J. F., Mann, G. J., Scolyer, R. A., Stow, J. L., Weninger, W., Haass, N. K., & Beaumont, K. A.
Venue
International Journal of Cancer
Publisher
Wiley
Published
2019-01-03
Volume
144
Issue
12
Pages
3070-3085
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W2905113713
Cited by
103
References
11
FWCI
3.22
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: RAB27A promotes melanoma cell invasion and metastasis via regulation of pro‐invasive exosomes. https://app.cochat.ai/papers/10.1002/ijc.32064
The paper
Guo, D., Lui, G. Y. L., Lai, S. L., Wilmott, J. S., Tikoo, S., Jackett, L. A., Quek, C., Brown, D. L., Sharp, D. M., Kwan, R. Y. Q., Chacon, D., Wong, J. H., Beck, D., van Geldermalsen, M., Holst, J., Thompson, J. F., Mann, G. J., Scolyer, R. A., Stow, J. L., . . . Beaumont, K. A. (2019). RAB27A promotes melanoma cell invasion and metastasis via regulation of pro‐invasive exosomes. International Journal of Cancer. https://doi.org/10.1002/ijc.32064

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.